A Phase II Study of Cabozantinib Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
Phase of Trial: Phase II
Latest Information Update: 07 Jun 2016
At a glance
- Drugs Cabozantinib (Primary) ; Trastuzumab (Primary)
- Indications Advanced breast cancer; Brain cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 07 Jun 2016 Interim results assessing effect of cabozantinib treatment on circulating immune cell (n = 35) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
- 23 Jan 2015 Status changed from not yet recruiting to recruiting according to ClinicalTrials.gov record.